[Corynebacterium parvum in advanced cancers. 1st evaluation of the therapeutic activity of this immunostimulin].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy; D003352:Corynebacterium; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology; D010166:Palliative Care; D011379:Prognosis; D014374:Tuberculin Test
D000970:Antineoplastic Agents
Le Corynebacterium parvum dans les cancers avancés. Premiére évaluation de l'activité thérapeutique de cette immuno-stimuline.